The DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.
Hypoxia signalling in cancer and approaches to enforce tumour regression
Abstract
Tumour cells emerge as a result of genetic alteration of signal circuitries promoting cell growth and survival, whereas their expansion relies on nutrient supply. Oxygen limitation is central in controlling neovascularization, glucose metabolism, survival and tumour spread. This pleiotropic action is orchestrated by hypoxia-inducible factor (HIF), which is a master transcriptional factor in nutrient stress signalling. Understanding the role of HIF in intracellular pH (pH(i)) regulation, metabolism, cell invasion, autophagy and cell death is crucial for developing novel anticancer therapies. There are new approaches to enforce necrotic cell death and tumour regression by targeting tumour metabolism and pH(i)-control systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The affinity of PHDs and FIH-1 for oxygen differs and, since FIH-1 has a higher affinity (lower K m ) for oxygen, PHDs are thought to be more rapidly inhibited in low oxygen conditions (Pouyssegur et al., 2006).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Pouyssegur et al., 2006
In the citing paper
“this is recognized to have profound effects on the tumor metabolism (92)(93)(94)”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [93]
In the citing paper
“O 2 tension in the center of solid tumors may be so low that cells essentially become anoxic”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [93]
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedThe biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,661
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302047 · Cited by 2,894
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Flagged first, then by citations
1 of the 104 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 801–900 of 1,002
Kaur, P., Nagar, S., Bhagwat, M., Uddin, M., Zhu, Y. B., Vancurova, I., & Vančura, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260400 · Cited by 37
Langhammer, S., Najjar, M., Hess‐Stumpp, H., & Thierauch, K. (2011) · Targeted Oncology · doi:10.1007/s11523-011-0184-7 · Cited by 36
Ratcliffe, P. J., Koivunen, P., Myllyharju, J., Ragoussis, J., Bovée, J. V. M. G., Batinic̈‐Haberle, I., Vinatier, C. S., Trichet, V., Robriquet, F., Oliver, L., et al. (2017) · Hypoxia · doi:10.2147/hp.s127042 · Cited by 35
Diverse activity of miR-150 in Tumor development: shedding light on the potential mechanisms
Ameri, A., Ahmed, H. M., Pecho, R. D. C., Arabnozari, H., Sarabadani, H., Esbati, R., Mirabdali, S., & Yazdani, O. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03105-3 · Cited by 35
Autophagy takes place in mutated p53 neuroblastoma cells in response to hypoxia mimetic CoCl2
Naves, T., Jawhari, S., Jauberteau, M., Ratinaud, M., & Verdier, M. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.01.022 · Cited by 39
Huang, Y., Ochieng, J. K., Kempen, M. B., Munck, A. B., Swagemakers, S. M. A., van IJcken, W. F. J., Grosveld, F. G., Tibboel, D., & Rottier, R. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057695 · Cited by 37
Hypoxia-driven splicing into noncoding isoforms regulates the DNA damage response
Memon, D., Dawson, K., Smowton, C., Wei, X., Dive, C., & Miller, C. J. (2016) · npj Genomic Medicine · doi:10.1038/npjgenmed.2016.20 · Cited by 36
Kim, J. H., Bae, H. C., Kim, J., Lee, H., Ryu, W., Son, E. D., Lee, T. R., Jeong, S. H., & Son, S. W. (2018) · Experimental Dermatology · doi:10.1111/exd.13785 · Cited by 35
Pandey, R. K., Heeger, S., & Lehner, C. F. (2007) · Journal of Cell Science · doi:10.1242/jcs.007690 · Cited by 37
Iron and colorectal cancer: evidence from in vitro and animal studies
Padmanabhan, H., Brookes, M., & Iqbal, T. H. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuu015 · Cited by 35
Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors
Faes, S., Planche, A., Uldry, É., Santoro, T., Pythoud, C., Stehle, J., Horlbeck, J., Letovanec, I., Riggi, N., Datta, D. B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9134 · Cited by 33
Badr, H. A., AlSadek, D. M. M., El-Houseini, M. E., Saeui, C. T., Mathew, M. P., Yarema, K. J., & Ahmed, H. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.044 · Cited by 34
Engineering biological gradients
Sardelli, L., Pacheco, D. P., Zorzetto, L., Rinoldi, C., Święszkowski, W., & Petrini, P. (2019) · Journal of Applied Biomaterials & Functional Materials · doi:10.1177/2280800019829023 · Cited by 35
Chandran, V. I., Welinder, C., de Oliveira, K. G., Cerezo-Magaña, M., Månsson, A., Johansson, M. C., Marko‐Varga, G., & Belting, M. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03262-4 · Cited by 36
Fu, C., An, N., Liu, J., Jun, A., Zhang, B., Liu, M., Zhang, Z., Fu, L., Tian, X., Wang, D., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012131 · Cited by 37
Yang, C. F., Su, M., Luo, P., Liu, Y., Yang, F., & Li, C. (2021) · Small · doi:10.1002/smll.202101180 · Cited by 34
Hypoxia‐inducible factor‐1α blocks differentiation of malignant gliomas
Lu, H., Li, Y., Shu, M., Tang, J., Huang, Y., Zhou, Y., Liang, Y., & Yan, G. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07441.x · Cited by 34
Uncovering the role of hypoxia inducible factor-1α in skin carcinogenesis
Nys, K., Maes, H., Dudek, A. M., & Agostinis, P. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.02.001 · Cited by 36
Shin, S.-J., Moon, K. C., Park, K. U., & Ha, E. (2012) · Biochimie · doi:10.1016/j.biochi.2012.03.023 · Cited by 34
Role Of Hif2α Oxygen Sensing Pathway In Bronchial Epithelial Club Cell Proliferation
Torres‐Capelli, M., Marsboom, G., Li, Q. O. Y., Tello, D., Meléndez‐Rodríguez, F., Alonso, T., Sánchez‐Madrid, F., Rio, F. G., Ancochea, J., & Aragonés, J. (2016) · Scientific Reports · doi:10.1038/srep25357 · Cited by 33
Ackerstaff, E., Artemov, D., Gillies, R. J., & Bhujwalla, Z. M. (2007) · Neoplasia · doi:10.1593/neo.07568 · Cited by 34
Inhibition of aberrant Hif1α activation delays intervertebral disc degeneration in adult mice
Wang, Z., Chen, H., Tan, Q., Huang, J., Zhou, S., Luo, F., Zhang, D., Yang, J., Li, C., Chen, B., et al. (2022) · Bone Research · doi:10.1038/s41413-021-00165-x · Cited by 35
Huang, N.-H., Tang, X., Meng, W., Lai, Y.-H., Zhou, X., Yu, X.-Z., Zhang, W., & Chen, J.-X. (2023) · ACS Nano · doi:10.1021/acsnano.3c04189 · Cited by 33
CD133 as a Marker for Regulation and Potential for Targeted Therapies in Glioblastoma Multiforme
Choy, W., Nagasawa, D. T., Trang, A., Thill, K., Spasić, M., & Yang, I. (2012) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2012.04.011 · Cited by 33
Chang, H., Liu, H., Lai, M.-D., Tsai, Y., Tzai, T., Cheng, H.-L., & Chow, N.-H. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3730 · Cited by 33
The clinicopathological and gene expression patterns associated with ulceration of primary melanoma
Jewell, R., Elliott, F., Laye, J. P., Nsengimana, J., Davies, J., Walker, C., Conway, C., Mitra, A., Harland, M., Cook, M. G., et al. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12315 · Cited by 33
Pedersen, A. K., de Melo, J. M. L., Mørup, N., Tritsaris, K., & Pedersen, S. F. (2017) · BMC Cancer · doi:10.1186/s12885-017-3532-x · Cited by 34
Zhang, G., Zhang, Y., Cheng, S., Wu, Z., Liu, F., & Zhang, J. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2566-x · Cited by 35
Holt‐Martyn, J. P., Chowdhury, R., Tumber, A., Yeh, T., Abboud, M. I., Lippl, K., Lohans, C. T., Langley, G. W., Figg, W. D., McDonough, M. A., et al. (2019) · ChemMedChem · doi:10.1002/cmdc.201900557 · Cited by 33
Nagata, S., Kokado, K., & Sada, K. (2019) · CrystEngComm · doi:10.1039/c9ce01731c · Cited by 33
Recent development of gene therapy for pancreatic cancer using non-viral nanovectors
Liu, Y., Wu, W., Wang, Y., Han, S., Yuan, Y., Huang, J., Shuai, X., & Peng, Z. M. (2021) · Biomaterials Science · doi:10.1039/d1bm00748c · Cited by 35
You, X., Sun, W., Wang, Y., Liu, X., Wang, A., Liu, L., Han, S., Sun, Y., Zhang, J., Guo, L., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02379-9 · Cited by 34
Role of Hypoxia-inducible factor-1α and Survivin in colorectal carcinoma progression
Fan, L., Dong, W., Jiang, C., Qian, Q., & Yu, Q. (2008) · International Journal of Colorectal Disease · doi:10.1007/s00384-008-0511-3 · Cited by 33
Robust metabolic adaptation underlying tumor progression
Vizán, P., Mazurek, S., & Cascante, M. (2008) · Metabolomics · doi:10.1007/s11306-007-0101-3 · Cited by 35
ARDent about acetylation and deacetylation in hypoxia signalling
Bilton, R. L., Trottier, E., Pouysségur, J., & Brahimi-Horn, M. C. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.10.002 · Cited by 34
Self-citationPhotoacid Generators for Biomedical Applications
Sun, T., Kang, L., Zhao, H., Zhao, Y., & Gu, Y. (2023) · Advanced Science · doi:10.1002/advs.202302875 · Cited by 34
Screening for possible miRNA–mRNA associations in a colon cancer cell line
Kanematsu, S., Tanimoto, K., Suzuki, Y., & Sugano, S. (2013) · Gene · doi:10.1016/j.gene.2013.08.005 · Cited by 32
Pinheiro, C. M., Garcia, E. A., Morais-Santos, F., Scapulatempo‐Neto, C., da Costa, A. M., Steenbergen, R. D. M., Boccardo, E., Villa, L. L., Baltazar, F., & Longatto‐Filho, A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-751 · Cited by 32
Hypoxia activates the IGF-1 expression through STAT5b in human HepG2 cells
Joung, Y.-H., Lee, M. Y., Lim, E.-J., Kim, M., Hwang, T. S., Kim, S., Ye, S., Lee, J.-D., Park, T., Woo, Y.-S., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.201 · Cited by 32
Zhang, X., Chen, Z., Zhang, T., & Wu, B. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s101872 · Cited by 32
Autophagy and TrkC/NT-3 signaling joined forces boost the hypoxic glioblastoma cell survival
Jawhari, S., Bessette, B., Hombourger, S., Durand, K., Lacroix, A., Labrousse, F., Jauberteau, M., Ratinaud, M., & Verdier, M. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx029 · Cited by 34
HIF-1α Promotes the Metastasis of Esophageal Squamous Cell Carcinoma by Targeting SP1
Hu, X., Lin, J., Jiang, M., He, X., Wang, K., Wang, W., Hu, C., Shen, Z., He, Z., Lin, H., et al. (2019) · Journal of Cancer · doi:10.7150/jca.35537 · Cited by 32
Hypoxia in Lung Cancer Management: A Translational Approach
Ancel, J., Perotin, J., Dewolf, M., Launois, C., Mulette, P., Nawrocki‐Raby, B., Dalstein, V., Gilles, C., Deslée, G., Polette, M., et al. (2021) · Cancers · doi:10.3390/cancers13143421 · Cited by 32
Chen, Q., Cuello‐Garibo, J., Bretin, L., Zhang, L., Ramu, V., Aydar, Y., Batsiun, Y., Bronkhorst, S., Husiev, Y., Beztsinna, N., et al. (2022) · Chemical Science · doi:10.1039/d2sc01646j · Cited by 32
Pentachlorophenol exposure causes Warburg-like effects in zebrafish embryos at gastrulation stage
Xu, T., Zhao, J., Hu, P., Dong, Z., Li, J., Zhang, H., Yin, D., & Zhao, Q. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.03.004 · Cited by 32
Zhang, M., Zhang, W., Wu, Z., Liu, S., Sun, L., Zhong, Y., Zhang, X., Kong, X., Qian, P., Zhang, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6572 · Cited by 31
Cancer cell migration and cancer drug screening in oxygen tension gradient chip
Nam, H., Funamoto, K., & Jeon, J. S. (2020) · Biomicrofluidics · doi:10.1063/5.0011216 · Cited by 34
Lactic acid in alternative polarization and function of macrophages in tumor microenvironment
Goswami, K. K., Banerjee, S., Bose, A., & Baral, R. (2022) · Human Immunology · doi:10.1016/j.humimm.2022.02.007 · Cited by 31
Su, Y. Y., Loos, M., Giese, N., Metzen, E., Büchler, M. W., Frieß, H., Kornberg, A., & Büchler, P. (2011) · Cancer · doi:10.1002/cncr.26344 · Cited by 31
Expected clinical applications of circulating tumor cells in breast cancer
Park, Y. (2011) · World Journal of Clinical Oncology · doi:10.5306/wjco.v2.i8.303 · Cited by 31
Lodi, A., Tiziani, S., Khanim, F. L., Drayson, M. T., Günther, U. L., Bunce, C. M., & Viant, M. R. (2010) · ACS Chemical Biology · doi:10.1021/cb900300j · Cited by 31
Spermine accelerates hypoxia-initiated cancer cell migration
Soda (2010) · International Journal of Oncology · doi:10.3892/ijo.2010.849 · Cited by 31
Wang, S., Cen, X. B., Liang, X., & Tang, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.12890 · Cited by 31
Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy
Khouzam, R. A., Lehn, J., Mayr, H., Clavien, P., Wallace, M. B., Ducreux, M. P., Limani, P., & Chouaïb, S. (2023) · Cancers · doi:10.3390/cancers15041235 · Cited by 33
Functional Imaging of Hypoxia: PET and MRI
Perez, R. C., Kim, D., Maxwell, A. W. P., & Camacho, J. C. (2023) · Cancers · doi:10.3390/cancers15133336 · Cited by 30
Yang, J., Zhou, Y., Cheng, X., Fan, Y., He, S., Li, S., Ye, H., Xie, C., Wu, W., Li, C., et al. (2015) · Scientific Reports · doi:10.1038/srep07697 · Cited by 30
Whole transcriptome RNA-seq analysis: tumorigenesis and metastasis of melanoma
Zhao, H., Li, Y., Wang, S., Yang, Y., Wang, J., Ruan, X., Yang, Y., Cai, K., Zhang, B., Cui, P., et al. (2014) · Gene · doi:10.1016/j.gene.2014.07.038 · Cited by 30
Chen, R.-Q., Yang, Q., Chen, Y., Oliveira, V. A., Dalton, W. S., Fearns, C., & Lee, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014316 · Cited by 30
Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer
Cui, X., Tinholt, M., Stavik, B., Dahm, A. E. A., Kanse, S. M., Jin, Y., Seidl, S., Sahlberg, K. K., Iversen, N., Skretting, G., et al. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13206 · Cited by 31
Oudin, M. J., Hughes, S. K., Rohani, N., Moufarrej, M. N., Jones, J. G., Condeelis, J. S., Lauffenburger, D. A., & Gertler, F. B. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9775-5 · Cited by 30
Impaired Neovascularization in Aging
Bonham, C. A., Kuehlmann, B. A., & Gurtner, G. C. (2019) · Advances in Wound Care · doi:10.1089/wound.2018.0912 · Cited by 31
Smit, M. A., van Pelt, G. W., Roodvoets, A. G. H., Kranenbarg, E. M., Putter, H., Tollenaar, R. A. �. �., van Krieken, J. H., & Mesker, W. E. (2019) · JMIR Research Protocols · doi:10.2196/13464 · Cited by 30
Lei, R., Zhang, S., Wang, Y., Dai, S., Sun, J., & Zhu, C. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.32157 · Cited by 32
Lin, P., Shi, J., Ming, L., Sheng, Y., Song, L., Hong, M., & Zhang, Y. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.135638 · Cited by 30
Nonlinear Modeling and Simulation of Tumor Growth
Vittorio Cristini, C., Frieboes, H. B., Li, X., Lowengrub, J. S., Macklin, P., Sanga, S., Wise, S. M., & Zheng, X. (2008) · Modeling and simulation in science, engineering & technology · doi:10.1007/978-0-8176-4713-1_6 · Cited by 31
Fernández‐Barral, A., Orgaz, J. L., Gómez, V., del Peso, L., Calzada, M. J., & Jiménez, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032989 · Cited by 30
Numata, M. (2011) · Oncology Reports · doi:10.3892/or.2011.1542 · Cited by 29
Zaťovičová, M., & Pastoreková, S. (2013) · Acta Virologica · doi:10.4149/av_2013_02_257 · Cited by 30
King, M. J., Bukantz, S. C., Phillips, S. E., Mohapatra, S. S., Tamulis, T., & Lockey, R. F. (2004) · PubMed · Cited by 30
Zheng, G., Zhou, M., Ou, X.-R., Peng, B., Yu, Y., Kong, F., Ouyang, Y., & He, Z. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07836.x · Cited by 29
Components of cancer metabolism and therapeutic interventions
Singleterry, J., Sreedhar, A., & Zhao, Y. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.05.010 · Cited by 28
Rajasekar, M., Kathiresan, S., & Sivakumar, K. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.08.019 · Cited by 29
Caveolin-3 plays a critical role in autophagy after ischemia-reperfusion
Kassan, A., Pham, U., Nguyen, Q., Reichelt, M. E., Cho, E., Patel, P. M., Roth, D. M., Head, B. P., & Patel, H. H. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00147.2016 · Cited by 27
Structural characterizations of human periostin dimerization and cysteinylation
Liu, J., Zhang, J., Xu, F., Lin, Z., Li, Z., & Liu, H. (2018) · FEBS Letters · doi:10.1002/1873-3468.13091 · Cited by 29
Nayak, A., Roy, A. D., Rout, N., Singh, S. P., Bhattacharyya, A., & Roychowdhury, A. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.12.130 · Cited by 29
Iikuni, S., Okada, Y., Shimizu, Y., Watanabe, H., & Ono, M. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00953 · Cited by 29
Kim, S., Park, S., Moon, E.-H., Kim, G. J., & Choi, J. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02924-8 · Cited by 30
Akt signaling is required for glioblastoma maintenance in vivo.
Robinson, J. P., VanBrocklin, M. W., McKinney, A. J., Gach, H. M., & Holmen, S. L. (2011) · Europe PMC (PubMed Central) · Cited by 29
Steunou, A., Ducoux‐Petit, M., Lazar, I., Monsarrat, B., Érard, M., Muller, C., Clottes, E., Burlet‐Schiltz, O., & Nieto, L. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.020727 · Cited by 35
Zhu, G., Peng, F., Gong, W. J., She, L., Wei, M., Tan, H., Chen, C., Zhang, D., Guo, L., Huang, D., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5949 · Cited by 30
Jia, Z., Zhang, J., Wang, Z., Wang, B., Wang, L., Cao, J., Tao, Z., & Hu, X. (2018) · Oncotarget · doi:10.18632/oncotarget.24246 · Cited by 29
Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme
Çetin, B., Gönül, İ. I., Gümüşay, Ö., Bilgetekin, İ., Algın, E., Özet, A., & Üner, A. (2018) · Neuropathology · doi:10.1111/neup.12485 · Cited by 29
Lysyl oxidase (LOX) and hypoxia-induced metastases
Mingo-Sion, A. M., & Figg, W. D. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.8.3230 · Cited by 29
Švastová, E., & Pastoreková, S. (2013) · Cell Adhesion & Migration · doi:10.4161/cam.23257 · Cited by 29
Metabolic consequences of treatment with AKT inhibitor perifosine in breast cancer cells
Su, J. S., Woods, S. M., & Ronen, S. M. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1764 · Cited by 28
Gankyrin is essential for hypoxia enhanced metastatic potential in breast cancer cells
Gao, L., Xie, H., Dong, L., Zou, J., Fu, J., GAO, X., Ou, L., Xiang, S., & Song, H. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1860 · Cited by 28
Protein kinase D2: a versatile player in cancer biology
Azoitei, N., Cobbaut, M., Becher, A., Lint, J. V., & Seufferlein, T. T. W. (2017) · Oncogene · doi:10.1038/s41388-017-0052-8 · Cited by 28
Mechanochemical generation of singlet oxygen
Türksoy, A., Yıldız, D., Aydonat, S., Bedük, T., Canyurt, M., Baytekin, B., & Akkaya, E. U. (2020) · RSC Advances · doi:10.1039/d0ra00831a · Cited by 28
Ledwon, J. K., Kelsey, L. J., Vaca, E. E., & Gosain, A. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-71823-z · Cited by 28
Li, J., Xu, P., Wu, D., Guan, M.-J., Weng, X., Lu, Y., Zeng, Y., & Chen, R. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04030-x · Cited by 28
Overcoming Radiation Resistance in Gliomas by Targeting Metabolism and DNA Repair Pathways
Meng, W., Palmer, J. D., Siedow, M. R., Haque, S. J., & Chakravarti, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042246 · Cited by 34
Nishiwaki, N., Noma, K., Ohara, T., Kunitomo, T., Kawasaki, K., Akai, M., Kobayashi, T., Narusaka, T., Kashima, H., Sato, H., et al. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03378-7 · Cited by 28
Yin, Y., Sun, P., Dong, H., Chen, Y., Chen, S., & Wang, L. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.108594 · Cited by 28
Oxygen Sensing: A Common Crossroad in Cancer and Neurodegeneration
Quaegebeur, A., & Carmeliet, P. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_83 · Cited by 27
Chang, Y.-W., Chen, M.-W., Chiu, C., Hong, C., Cheng, C.-C., Hsiao, M., Chen, C., Wei, L., & Su, J.-L. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3812-5 · Cited by 28
Hypoxia-inducible factor-1: A possible link between inhalational anesthetics and tumor progression?
Zhao, H., Iwasaki, M., Yang, J., Savage, S., & Ma, D. (2014) · Acta anaesthesiologica Taiwanica · doi:10.1016/j.aat.2014.05.008 · Cited by 28
The hypoxia-mimetic agent CoCl2 induces chemotherapy resistance in LOVO colorectal cancer cells
YANG, G., XU, S., PENG, L., Li, H., Zhao, Y., & Hu, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4836 · Cited by 29
Nan, Y., Wu, X., Luo, Q., Chang, W., Zhao, P., Zhang, L., & Liu, Z. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2315348121 · Cited by 27
Benzothiazole derivatives in the design of antitumor agents
Paoletti, N., & Supuran, C. T. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202400259 · Cited by 27
Zeng, Y., Yao, X., Yan, Z., Liu, J., & Liu, X. (2016) · Oncology Letters · doi:10.3892/ol.2016.4661 · Cited by 27
Metadata
- Authors
- Pouysségur, J., Dayan, F., & Mazure, N. M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Pouysségur, Jacques
- Venue
- Nature
- Published
- 2006-05-24
- Volume
- 441
- Issue
- 7092
- Pages
- 437-443
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2082483448
- Semantic Scholar
- 5bbdcf74ee4cdf263a532b6dbae0b8dd5efb9722
- Cited by
- 1,676
- References
- 104
- Citations by year
- 2026: 19 · 2025: 39 · 2024: 48 · 2023: 75 · 2022: 85 · 2021: 97 · 2020: 87 · 2019: 77 · 2018: 81 · 2017: 68 · 2016: 85 · 2015: 80 · 2014: 103 · 2013: 104 · 2012: 89
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Ligue Contre le Cancer
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- hypoxia signaling, hypoxia-inducible factor, tumor hypoxia, tumor regression, cancer metabolism, intracellular pH regulation, tumor angiogenesis, glucose metabolism, necrosis, autophagy, cell invasion, cancer therapy, tumor oxygenation
- MeSH terms
- Animals, Humans, Neoplasms, Neovascularization, Pathologic, Oxygen, Protein Kinases, Signal Transduction, Cell Hypoxia, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review